[HTML][HTML] The foundation and architecture of precision medicine in neurology and psychiatry

H Hampel, P Gao, J Cummings, N Toschi… - Trends in …, 2023 - cell.com
Neurological and psychiatric diseases have high degrees of genetic and pathophysiological
heterogeneity, irrespective of clinical manifestations. Traditional medical paradigms have …

The complex pathway between amyloid β and cognition: implications for therapy

WJ Jagust, CE Teunissen, C DeCarli - The Lancet Neurology, 2023 - thelancet.com
For decades, the hypothesis that brain deposition of the amyloid β protein initiates
Alzheimer's disease has dominated research and clinical trials. Targeting amyloid β is …

Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid …

R Ossenkoppele, R Smith, N Mattsson-Carlgren… - JAMA …, 2021 - jamanetwork.com
Importance Tau positron emission tomography (PET) tracers have proven useful for the
differential diagnosis of dementia, but their utility for predicting cognitive change is unclear …

Biomarker-based prediction of longitudinal tau positron emission tomography in Alzheimer disease

A Leuzy, R Smith, NC Cullen, O Strandberg… - JAMA …, 2022 - jamanetwork.com
Importance There is currently no consensus as to which biomarkers best predict longitudinal
tau accumulation at different clinical stages of Alzheimer disease (AD). Objective To …

Age-related and amyloid-beta-independent tau deposition and its downstream effects

A Wuestefeld, A Pichet Binette, D Berron, N Spotorno… - Brain, 2023 - academic.oup.com
Amyloid-β (Aβ) is hypothesized to facilitate the spread of tau pathology beyond the medial
temporal lobe. However, there is evidence that, independently of Aβ, age-related tau …

Neuroprotective mechanisms of ginsenoside Rb1 in central nervous system diseases

L Gong, J Yin, Y Zhang, R Huang, Y Lou… - Frontiers in …, 2022 - frontiersin.org
Panax ginseng and Panax notoginseng, two well-known herbs with enormous medical
value in Asian countries, have a long usage history in China for the therapy of some …

Regional tau deposition reflects different pathways of subsequent neurodegeneration and memory decline in cognitively normal older adults

X Chen, TN Toueg, TM Harrison, SL Baker… - Annals of …, 2024 - Wiley Online Library
Objective Tau pathology is recognized as a primary contributor to neurodegeneration and
clinical symptoms in Alzheimer's disease (AD). This study aims to localize the early tau …

Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults

E Rodriguez-Vieitez, V Montal, J Sepulcre, C Lois… - Molecular …, 2021 - nature.com
Noninvasive biomarkers of early neuronal injury may help identify cognitively normal
individuals at risk of developing Alzheimer's disease (AD). A recent diffusion-weighted …

Genetically identical twins show comparable tau PET load and spatial distribution

EM Coomans, J Tomassen, R Ossenkoppele… - Brain, 2022 - academic.oup.com
Tau accumulation starts during the preclinical phase of Alzheimer's disease and is closely
associated with cognitive decline. For preventive purposes, it is important to identify factors …

Thioredoxin-1 inhibits amyloid-β25–35-induced activation of NLRP1/caspase-1/GSDMD pyroptotic pathway in PC12 cells

J Jia, X Zhang, G Xu, X Zeng, L Li - Molecular Biology Reports, 2022 - Springer
Background Alzheimer's disease (AD), the most common neurodegenerative disease, is
charactered by these accepted pathological features, such as β-amyloid (Aβ) plaques …